Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Infiltration Analgesia with Ropivacaine in Caesarean Section
NCT00891540Phase 4
Key facts
- Status
- Completed
- Start
- Jul 2009
- Primary completion
- May 2010
- Countries
- 1
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Modality
- Orthosteric Ligands
- Drugs
- ropivacaine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (3 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Postoperative pain at 24 hours. Started Jul 2009; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
Ropivacaine 0.5%
Local infiltration with Ropivacaine 0.5%
Ropivacaine 0.2%
Local infiltration with Ropivacaine 0.2%
Placebo
Local infiltration with Isotonic NaCl
03
Who it enrols
Patients eligible for elective caesarean section, able to speak Danish and give informed consent. Excludes patients with alcohol/medical abuse, allergies to local anesthetics, or intolerance to opioids.
04
Endpoints
Primary
Postoperative pain
Secondary
Postoperative nausea and vomiting
Beyond the preview
Go deeper on NCT00891540.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891540.